Literature DB >> 8605923

Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12.

T Jung1, J Wijdenes, C Neumann, J E de Vries, H Yssel.   

Abstract

Interleukin (IL)-13 is a cytokine originally identified as a product of activated T cells. Little is known however, about IL-13 production by human T cells and its modulation by other cytokines. Here, we show that IL-13 is produced by activated human CD4+ and CD8+ CD45RO+ memory T cells and CD4+ and CD8+ CD45RA+ naive T cells. In contrast, IL-4, which shares many biological activities with IL-13, is only produced by CD45RO+ T cells following activation. Analysis of intracellular cytokine production by single CD45RA+ and CD45RO+ T cells indicated that IL-13 continued to be produced for more than 24 h after stimulation, whereas IL-4 could not be detected after 24 h. These data were confirmed by measurement of specific mRNA and suggest that IL-13, unlike IL-4, but like interferon-gamma (IFN-gamma), is a cytokine with long-lasting kinetics. The majority of human CD45RO+ T cells produced IL-4 and IL-13 simultaneously. In contrast, IFN-gamma protein was generally not co-expressed with IL-4 or IL-13. IL-4 added to primary cultures of highly purified peripheral blood T cells activated by the combination of anti-CD3+anti-CD28 mAb enhanced IL-13 production by CD45RA+ and to a lesser extent by CD45RO+ T cells. Under these conditions, however, IL-12 inhibited IL-13 production by CD45RA+ T cells and to a lesser extent by CD45RO+ T cells in a dose-dependent fashion. These inhibiting effects were not related to enhanced IFN-gamma production induced by IL-12, since IFN-gamma by itself did not affect IL-13 production. Collectively, our data indicate that IL-13 is produced by peripheral blood T cells which also produce IL-4, but not IFN-gamma, and by naive CD45RA+ T cells which, in contrast, fail to produce IL-4. These observations, together with the long-lasting production of IL-13, suggest that IL-13 may have IL-4 like functions in situations where T cell-derived IL-4 is still absent or where its production has already been down-regulated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605923     DOI: 10.1002/eji.1830260311

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression.

Authors:  S Till; S Durham; R Dickason; D Huston; J Bungre; S Walker; D Robinson; A B Kay; C Corrigan
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

2.  Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels.

Authors:  Grazia Galli; Duccio Medini; Erica Borgogni; Luisanna Zedda; Monia Bardelli; Carmine Malzone; Sandra Nuti; Simona Tavarini; Chiara Sammicheli; Anne K Hilbert; Volker Brauer; Angelika Banzhoff; Rino Rappuoli; Giuseppe Del Giudice; Flora Castellino
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

3.  The role of IL-13 in IgE synthesis by allergic asthma patients.

Authors:  T C Van der Pouw Kraan; J S Van der Zee; L C Boeije; E R De Groot; S O Stapel; L A Aarden
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

4.  Synovial fluid T cells from patients with rheumatoid arthritis are refractory to the T helper type 2 differentiation-inducing effects of interleukin-4.

Authors:  P Isomäki; R Luukkainen; O Lassila; P Toivanen; J Punnonen
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

5.  Differences in regulatory pathways identify subgroups of T cell-derived Th2 cytokines.

Authors:  K Rafiq; D M Bullens; A Kasran; K Lorré; J L Ceuppens; S W Van Gool
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

6.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production.

Authors:  Z Zhu; R J Homer; Z Wang; Q Chen; G P Geba; J Wang; Y Zhang; J A Elias
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

7.  IL-23 receptor regulation by Let-7f in human CD4+ memory T cells.

Authors:  Zhaoxia Li; Feng Wu; Steven R Brant; John H Kwon
Journal:  J Immunol       Date:  2011-04-20       Impact factor: 5.422

8.  Polymorphisms of IL-13 and IL-4-IL-13-SNPs in patients with penicillin allergies.

Authors:  Jing Yang; Hai-Ling Qiao; Zi-Ming Dong
Journal:  Eur J Clin Pharmacol       Date:  2005-11-17       Impact factor: 2.953

9.  Th1/Th2 patterns and balance in cytokine production in the parents and infants of a large birth cohort.

Authors:  Marilyn Halonen; I Carla Lohman; Debra A Stern; Amber Spangenberg; Dayna Anderson; Sara Mobley; Kathy Ciano; Michael Peck; Anne L Wright
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls.

Authors:  L Büdinger; L Borradori; C Yee; R Eming; S Ferencik; H Grosse-Wilde; H F Merk; K Yancey; M Hertl
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.